Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis

Ivermectin (Mectizan(®)) is the only drug currently recommended for the treatment and control of onchocerciasis. Serious adverse events rarely occur during treatment, except in subjects heavily infected with Loa Loa. This review of drug-related serious adverse events in the treatment of onchocercias...

Descripción completa

Detalles Bibliográficos
Autor principal: Awadzi, Kwablah
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147654/
https://www.ncbi.nlm.nih.gov/pubmed/14975063
http://dx.doi.org/10.1186/1475-2883-2-S1-S6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147654/
https://www.ncbi.nlm.nih.gov/pubmed/14975063
http://dx.doi.org/10.1186/1475-2883-2-S1-S6

Ejemplares similares